Mesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Tuesday, July 7th, Wall Street Journal reports. Shareholders of record on Monday, August 31st will be paid a dividend of 0.16 per share by the medical instruments supplier on Tuesday, September 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date of this dividend is Friday, August 28th.
Mesa Laboratories has a payout ratio of 16.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $7.01 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 9.1%.
NASDAQ:MLAB traded up $5.41 during mid-day trading on Tuesday, reaching $222.34. 46,900 shares of the company were exchanged, compared to its average volume of 43,570. Mesa Laboratories has a 12 month low of $181.90 and a 12 month high of $271.46. The company has a fifty day moving average of $234.56 and a 200 day moving average of $239.41. The company has a quick ratio of 4.17, a current ratio of 4.72 and a debt-to-equity ratio of 0.64. The stock has a market cap of $953.74 million, a PE ratio of 532.27 and a beta of 0.37.
Mesa Laboratories (NASDAQ:MLAB) last issued its earnings results on Monday, June 1st. The medical instruments supplier reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.15). The business had revenue of $34.21 million during the quarter, compared to the consensus estimate of $34.50 million. Mesa Laboratories had a net margin of 1.15% and a return on equity of 8.92%. On average, equities research analysts anticipate that Mesa Laboratories will post 6.4 EPS for the current fiscal year.
Several research analysts have recently issued reports on MLAB shares. ValuEngine lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Friday, May 1st. BidaskClub lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Friday, June 12th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Mesa Laboratories has an average rating of “Hold” and an average target price of $273.67.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.
Recommended Story: What is insider trading?
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.